Johnson & Johnson To Determine If COVID Vaccine Is In Works

JOHNSON & JOHNSON REPORTS ITS JANSSEN COVID-19 VACCINE TRIAL IS STILL ON TRACK AND COLLECTING DATA

(CNN) – Johnson & Johnson says its coronavirus vaccine trial is still on track.

The company says it should have enough data soon to determine if its Janssen COVID-19 vaccine is safe and provides protection against the novel coronavirus.

The Janssen vaccine is a single dose shot unlike those made by Moderna and Pfizer/Biontech.

Johnson & Johnson is aiming to have its data “toward the end of January.”

It hopes to submit an emergency use authorization application to the US Food and Drug Administration in February.

Categories: Business, US News